The effects of chronic methylphenidate administration on operant test battery performance in juvenile rhesus monkeys

Neurotoxicology and Teratology

Volumn 32, Issue 2, 2010, Pages 142-151

  Rodriguez, J S ^a   Morris, S M ^a   Hotchkiss, C E ^a   Doerge, D R ^a   Allen, R R ^b   Mattison, D R ^c   Paule, M G ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b Peak Statistical Services   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Attention; Juvenile; Learning; Memory; Methylphenidate; Operant

Indexed keywords

METHYLPHENIDATE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CHRONIC DRUG ADMINISTRATION; COGNITION; CONTROLLED STUDY; DISCRIMINATION LEARNING; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MEGADOSE; DRUG TOLERABILITY; INSTRUMENTAL CONDITIONING; JUVENILE ANIMAL; LOW DRUG DOSE; MALE; MENTAL TASK; MORNING DOSAGE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SHORT TERM MEMORY; TASK PERFORMANCE;

AGE FACTORS; AGING; ANIMALS; APPETITE; APPETITE DEPRESSANTS; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; MACACA MULATTA; MALE; METHYLPHENIDATE; MOTIVATION; NEUROPSYCHOLOGICAL TESTS; TIME;

ANIMALIA; MACACA MULATTA; PRIMATES;

EID: 77649276003     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2009.08.011     Document Type: Article

References (44)

1. Arnsten A.F. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology 31 11 (2006) 2376-2383
2. Arnsten A.F. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J. Clin. Psychiatry 67 Suppl 8 (2006) 7-12
3. Barkley R.A., McMurray M.B., Edelbrock C.S., and Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 86 (1990) 184-192
4. Bedford J.A., Marquis D.K., and Wilson M.C. The effects of several anorexigenics on monkey social behavior. Pharmacol. Biochem. Behav. 20 3 (1984) 317-321
5. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F., Kelley A.E., Schmeichel B., Hamilton C., and Spencer R.C. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol. Psychiatry 60 10 (2006) 1111-1120 (15)
6. Bolanos C.A., Barrot M., Berton O., Wallace-Black D., and Nestler E.J. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol. Psychiatry 54 12 (2003) 1317-1329
7. Chelonis J.J., Daniels-Shaw J.L., Blake D.J., and Paule M.G. Developmental aspects of delayed matching-to-sample task performance in children. Neurotoxicol. Teratol. 22 5 (2000) 683-694
8. Chelonis J.J., Flake R.A., Baldwin R.L., Blake D.J., and Paule M.G. Developmental aspects of timing behavior in children. Neurotoxicol. Teratol. 26 (2004) 461-476
9. Dafny N., and Yang P.B. The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Res. Bull. 68 6 (2006) 393-405
10. Doerge D.R., Fogle C.M., Paule M.G., McCullagh M., and Bajic S. Analysis of methylphenidate and its metabolite ritalinic acid in monkey plasma by liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 14 8 (2000) 619-623
11. El-Zein R.A., Abdel-Rahman S.Z., Hay M.J., Lopez M.S., Bondy M.L., Morris D.L., and Legator M.S. Cytogenetic effects in children treated with methylphenidate. Cancer Lett. 230 (2005) 284-291
12. Firestone P., Musten L.M., Pisterman S., Mercer J., and Bennett S. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study. J. Child Adolesc. Psychopharmacol. 8 (1998) 13-25
13. Fujita S., Okutsu H., Yamaguchi H., Nakamura S., Adachi K., Saigusa T., and Koshikawa N.J. Altered pre- and postsynaptic dopamine receptor functions in spontaneously hypertensive rat: an animal model of attention-deficit hyperactivity disorder. Oral Sci. 45 2 (2003) 75-83
14. Goez H., Back-Bennet O., and Zelnik N. Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder. J. Child Neurol. 22 5 (2007) 538-542
15. Heyser C.J., Pelletier M., and Ferris J.S. The effects of methylphenidate on novel object exploration in weanling and periadolescent rats. Ann. N. Y. Acad. Sci. 1021 (2004) 465-469
16. Klein-Schwartz W. Pediatric methylphenidate exposures: 7-year experience of poison centers in the United States. Clin. Pediatr. (Phila) 42 2 (2003) 159-164
17. LeBlanc-Duchin D., and Taukulis H.K. Chronic oral methylphenidate administration to periadolescent rats yields prolonged impairment of memory for objects. Neurobiol. Learn. Mem. 88 3 (2007) 312-320
18. Mayers R., Bagwell C., and Erkulwater J. ADHD and the rise in stimulant use among children. Harv. Rev. Psychiatry 16 3 (2008) 151-166
19. Morris P., Gillam M.P., Allen R.R., and Paule M.G. The effect of chronic cocaine exposure during pregnancy on the acquisition of operant behaviors by rhesus monkey offspring. Neurotoxicol. Teratol. 18 (1996) 155-166
20. Morris P., Gillam M., McCarty C., and Paule M.G. Effects of chronic methylphenidate on operant behavior in the rhesus monkey. Toxicologist 36 1 (1997) 63
21. Morris P., Gillam M.P., Parker J., McCarty C., and Paule M.G. Effects of chronic methylphenidate on operant behavior in the rhesus monkey II. Toxicologist 42 1-S (1998) 304
22. Morris S.M., Dobrovolsky V.N., Shaddock J.G., Mittelstaedt R.A., Bishop M.E., Manjanatha M.G., Shelton S.D., Doerge D.R., Twaddle N.C., Chen J.J., Lin C.J., Paule M.G., Slikker Jr. W., Hotchkiss C.E., Petibone D., Tucker J.D., and Mattison D.R. The genetic toxicology of methylphenidate hydrochloride in non-human primates. Mutat. Res. 673 1 (2009) 59-66
23. National Toxicology Program, U.S. Department of Health and Human Services, NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Methylphenidate. NIH Publication No. 05-4473 (2005)
24. Paule M.G. Age-related sensitivity to the acute behavioral effects of cocaine and amphetamine in monkeys. Neurotox. Teratol. 19 3 (1997) 241-242
25. Paule M.G. Validation of a behavioral test battery for monkeys. In: Buccafusco J.J. (Ed). Methods of Behavioral Analysis in Neuroscience (2001), CRC Press LLC, Boca Raton, FL 281-294
26. Paule M.G. Chronic drug exposures during development in nonhuman primates: models of brain dysfunction in humans. In: Taffe M., and Weed M.R. (Eds). Frontiers in Bioscience Special Issue: Nonhuman Primate Models of Neuropsychopathology. Frontiers in Bioscience vol. 10 (2005) 2240-2249
27. Paule M.G., Cranmer J.M., Wilkins J.D., Stern H.P., and Hoffman E.L. Quantitation of complex brain function in children: preliminary evaluation using a nonhuman primate behavioral test battery. Neurotoxicology 9 (1988) 367-378
28. Paule M.G., Gillam M.P., and Morris P. The effects of cocaine on nonhuman primate brain function are age-dependent. Ann. N.Y. Acad. Sci. 844 (1998) 178-182
29. Paule M.G., Chelonis J.J., Buffalo E.A., Blake D.J., and Casey P.H. Operant test battery performance in children: correlation with IQ. Neurotoxicol. Teratol. 21 (1999) 223-230
30. Popke E.J., Allen R.R., Pearson E.C., Hammond T.G., and Paule M.G. Differential effects of two NMDA receptor antagonists on cognitive-behavioral development in nonhuman primates I. Neurotoxicol. Teratol. 23 (2001) 319-332
31. Popke E.J., Allen R.R., Pearson E.C., Hammond T.G., and Paule M.G. Differential effects of two NMDA receptor antagonists on cognitive-behavioral performance in young nonhuman primates II. Neurotoxicol. Teratol. 23 (2001) 333-347
32. Prendergast M.A., Jackson W.J., Terry Jr. A.V., Kille N.J., Arneric S.P., Decker M.W., and Buccafusco J.J. Age-related differences in distractibility and response to methylphenidate in monkeys. Cereb. Cortex 8 2 (1998) 164-172
33. Quinn D., Wigal S., Swanson J., Hirsch S., Ottolini Y., Dariani M., Roffman M., Zeldis J., and Cooper T. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psych. 43 11 (2004) 1422-1429
34. Roffman J.L., and Raskin L.A. Stereotyped behavior: effects of d-amphetamine and methylphenidate in the young rat. Pharmacol. Biochem. Behav. 58 4 (1997) 1095-1102
35. Schulze G.E., McMillan D.E., Bailey J.R., Scallet A.C., Ali S.F., Slikker Jr. W., and Paule M.G. Acute effects of delta-9-tetrahydrocannabinol (THC) in rhesus monkeys as measured by performance in a battery of cognitive function tests. J. Pharmacol. Exp. Ther. 245 1 (1988) 178-186
36. Schulze G.E., McMillan D.E., Bailey J.R., Scallet A.C., Ali S.F., Slikker Jr. W., and Paule M.G. Acute effects of marijuana smoke on complex operant behavior in rhesus monkeys. Life Sci. 45 6 (1989) 465-475
37. Sleator E.K. Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette syndrome. Clin. Pediatr. (Phila) 19 7 (1980) 453-454
38. Volkow N.D., and Insel T.R. What are the long-term effects of methylphenidate treatment?. Biol. Psychiatry 54 (2003) 1307-1309
39. Volkow N.D., and Swanson J.M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am. J. Psychiatry 160 (2003) 1909-1918
40. Volkow N.D., Fowler J.S., Wang G., Ding Y., and Gatley S.J. Mechanism of action of methylphenidate: insights from PET imaging studies. J. Atten. Disord. 6 Suppl 1 (2002) S31-43
41. Volkow N.D., Wang G.J., Newcorn J., Telang F., Solanto M.V., Fowler J.S., Logan J., Ma Y., Schulz K., Pradhan K., Wong C., and Swanson J.M. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 64 8 (2007) 932-940
42. Wilens T.E., Hammerness P.G., Biederman J., Kwon A., Spencer T.J., Clark S., Scott M., Podolski A., Ditterline J.W., Morris M.C., and Moore H. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J. Clin. Psychiatry 66 (2005) 253-259
43. Yang P.B., Swann A.C., and Dafny N. Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization. Brain Res. 1145 (2007) 66-80
44. Zhu N., Weedon J., and Dow-Edwards D.L. Oral methylphenidate improves spatial learning and memory in pre- and periadolescent rats. Behav. Neurosci. 121 6 (2007) 1272-1279